All CJC-1295 (No DAC) certificates

CJC-1295 (No DAC) 10 mg Certificate of Analysis Batch APL-CJC10-2607-02

CJC-1295 (No DAC) 10 mg from batch APL-CJC10-2607-02 was analysed on 19 July 2026 and measured 98.63% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity
98.63%
Result
All 5 tests passed
Tested
19 July 2026
Method
HPLC / Mass Spectrometry
Net content
10.14 mg

Independent verification

CJC-1295 (No DAC) 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.48% purity by UPLC-MS/MS, analysed 28 August 2026 on lot APL-CJC5-2608-01, net content 4.88 mg, verification code OZ-HPLCMS-TS04; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 30 August 2026, verification code OZ-ENDOTX-TAU1.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis CJC-1295 (No DAC) 10 mg Batch APL-CJC10-2607-02
Compound
CJC-1295 (No DAC)
Lot Number
APL-CJC10-2607-02
Analysis Date
19 July 2026
Method
HPLC / Mass Spectrometry
Purity
98.63%
Net Content
10.14 mg
CJC-1295 (No DAC) vial
Formula
C152H252N44O42
Molecular Weight
3367 g/mol
Form
Lyophilised Powder
Manufactured
July 2026
Issued
20 July 2026
Document ID
APL-COA-CJC10-2607-02
Verification Code
Batch traceable
SequenceTyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm0250500750100033.544.555.566.5 min 3.6953.9224.074CJC-1295 (No DAC)4.5585.687

Main peak integrated at 98.63% of total area; no single impurity peak exceeds 0.53%.

Peak List

Peaks detected: 5
#Time (min)Area% AreaIdentification
13.69526,8090.400—
23.92235,3570.530—
34.0746,640,51798.630CJC-1295 (No DAC)
44.55818,6880.280—
55.68710,7430.160—

Analytical Results

TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)ConfirmedConfirmedPASS
Purity (HPLC)≥98.0%98.63%PASS
Peptide Content95–105%98.2%PASS
Endotoxins<0.5 EU/mg<0.10 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

CJC-1295 (No DAC) 10 mg

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 July 2026
Monitored (m/z)Detected (m/z)Relative Intensity
674674.421.74
843842.763.38
11231123.351.28

Detection assignment: CJC-1295 (No DAC)

Collected Mass Spectrum

Intensity ×107

01234300500700900110013001500 m/z 6748431123

Verification Protocol

  • Identity confirmed by mass spectrometry against the expected ion channels.
  • Purity measured by HPLC as peak area against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View CJC-1295 (No DAC) in the catalogueHow to read this certificate